Altius Strategy Consulting

 

Reaching higher goals in healthcare

ALTIUS: THE LATIN WORD FOR HIGHER


Altius Strategy Consulting helps its clients attain higher goals in addressing

critical unmet medical needs through product Value Development Planning.

Altius Strategy Consulting helps companies plan for successful pricing, reimbursement, market access and adoption of medical products through the creation and demonstration of product value. 


Altius specializes in a multidisciplinary approach to product analyses that integrates scientific, clinical, regulatory, health economic, health-related quality of life, and market information. 


Altius works closely with its clients’ senior teams, providing insights and advice to inform product development decisions.


Altius understands the increasingly demanding evidence requirements of market stakeholders. It incorporates this understanding into its strategic assessments, creating effective commercialization strategies and value development plans for products in late preclinical and clinical development.

News / Events:


January 7, 2019, The Boston Globe quotes Altius’ Principal Leora Schiff on the 2019 outlook for biotech stocks


January 4, 2019, US Dept. of HHS makes available for download the final report “Cost Drivers in the Development and Validation of Biomarkers Used in Drug Development” - Altius’ Principal Leora Schiff served as subject matter expert for the report


January 3, 2019, Timmerman Report publishes “Medicare’s CAR (-T) Wreck, an article by Altius’ Principal Leora Schiff on the confusion and misalignment in Medicare reimbursement for CAR-T therapies






© Altius Strategy Consulting 2019